Envestnet Asset Management
NAMS icon

Envestnet Asset Management’s NewAmsterdam Pharma NAMS Stock Holding History

Envestnet Asset Management’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$498K Sell
15,550
-2,022
-12% -$65.9K ﹤0.01% 3939
2025
Q4 		$616K Buy
+17,572
New +$639K ﹤0.01% 3565
2025
Q1 		– Sell
-9,359
Closed -$241K – 4435
2024
Q4 		$241K Sell
9,359
-8,738
-48% -$186K ﹤0.01% 4002
2024
Q3 		$300K Sell
18,097
-1,067
-6% -$18.5K ﹤0.01% 3821
2024
Q2 		$368K Buy
19,164
+10,125
+112% +$203K ﹤0.01% 3615
2024
Q1 		$214K Buy
+9,039
New +$183K ﹤0.01% 3914

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DFO
Duquesne Family Office New York $2.94B AUM 61.92% 1-Year Est. Return